By Martin Burns
The dispute between Johnson & Johnson (J&J) and Novartis over new contact lens technology has finally come to an end, Optician Online has reported.
For months, J&J Vision Care and the CIBA Vision division of Novartis have been at odds over CIBA's 'Nicholson' patents for silicone hydrogel contact lens technology, but J&J will now be allowed to licence it.
The settlement brings to end litigation on both sides of the Atlantic and will cover the entire portfolio of Johnson & Johnson silicone hydrogel contact lenses, the website reports.
This includes Acuvue Oasys, Acuvue Advance and 1-Day Acuvue TruEye and will "allow J&J to continue to manufacture, market and sell its silicone hydrogel contact lenses on a worldwide basis under a licence from CIBA, including markets under court-ordered injunction", Optician Online said.
Last month, an agreement was reached for vision specialist Novartis to purchase Alcon, which will give Novartis control over 70 per cent of the global vision market.
by Adrian Galbreth